NON-HODGKIN LYMPHOMA,B CELL
Clinical trials for NON-HODGKIN LYMPHOMA,B CELL explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA,B CELL trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA,B CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Living Drug' trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new, single-infusion CAR-T cell therapy called SynKIR-310. It is for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments, including other CAR-T …
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for lymphoma patients who have run out of options
Disease control Recruiting nowThis study is testing a new drug called MEN1703, both by itself and combined with another drug (glofitamab), for people with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. It aims to see if these treatments are safe and can hel…
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis early-stage trial is testing the safety and finding the right dose of a new type of CAR-T cell therapy called BRL-201 for adults with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to standard treatments. Doctors will collect a patient's own immune cells,…
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: PHASE1 • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Early trial tests 'Off-the-Shelf' cell therapy for tough lymphoma cases
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called universal CAR-T for adults with B-cell non-Hodgkin lymphoma that has returned or not responded to other treatments. Doctors will give a single dose of these specially engineered immune cells to 3-6 patients to ch…
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: NA • Sponsor: Bioray Laboratories • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for cancer patients with failing kidneys
Disease control Recruiting nowThis study is testing whether a powerful cancer treatment called CAR-T therapy can be safely given to people with moderate to severe kidney problems. Researchers are adjusting the dose of the chemotherapy drugs given right before the CAR-T cells to see if it reduces serious side …
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Spinal fluid test could spot hidden brain cancer in lymphoma patients
Diagnosis Recruiting nowThis study is testing whether a new liquid biopsy method can better detect when aggressive B-cell lymphoma has spread to the brain and spinal cord. Researchers will compare this new test, which looks for tumor DNA in spinal fluid, against current standard diagnostic methods. The …
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Phase: NA • Sponsor: Swiss Cancer Institute • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Could muscle loss predict who does best with advanced lymphoma treatment?
Knowledge-focused Recruiting nowThis study aims to understand if muscle loss or a patient's overall health status can predict how well someone responds to CAR-T cell therapy for B-cell lymphoma. Researchers will observe 130 adult patients already scheduled to receive this treatment. They will measure muscle mas…
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Massive italian study tracks 1500 lymphoma patients on Cutting-Edge antibody drugs
Knowledge-focused Recruiting nowThis study is observing how newer antibody treatments work for B-cell non-Hodgkin lymphoma in everyday Italian clinics. It will follow 1,500 patients already scheduled to receive these approved treatments to collect real-world data on effectiveness, side effects, and long-term ou…
Matched conditions: NON-HODGKIN LYMPHOMA,B CELL
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC